Dr. Thomas Karasic, MD
Claim this profileUniversity of Pennsylvania
Studies Liver Cancer
Studies Pancreatic Cancer
9 reported clinical trials
17 drugs studied
Area of expertise
1Liver Cancer
Stage III
Stage IV
2Pancreatic Cancer
Stage IV
TP53 positive
Affiliated Hospitals
Clinical Trials Thomas Karasic, MD is currently running
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria
TOS-358
for Cancer
This trial tests TOS-358, a new drug for adults with specific cancers that have a genetic mutation. It aims to find the safest dose and see how well patients tolerate it. The drug works by blocking a gene that helps cancer cells grow.
Recruiting1 award Phase 1
More about Thomas Karasic, MD
Clinical Trial Related5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Thomas Karasic, MD has experience with
- Nivolumab
- Pembrolizumab
- BMS-986253
- Cabiralizumab
- Nab-paclitaxel
- Paricalcitol
Breakdown of trials Thomas Karasic, MD has run
Liver Cancer
Pancreatic Cancer
Squamous Cell Carcinoma
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Karasic, MD specialize in?
Thomas Karasic, MD focuses on Liver Cancer and Pancreatic Cancer. In particular, much of their work with Liver Cancer has involved Stage III patients, or patients who are Stage IV.
Is Thomas Karasic, MD currently recruiting for clinical trials?
Yes, Thomas Karasic, MD is currently recruiting for 3 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Thomas Karasic, MD has studied deeply?
Yes, Thomas Karasic, MD has studied treatments such as Nivolumab, Pembrolizumab, BMS-986253.
What is the best way to schedule an appointment with Thomas Karasic, MD?
Apply for one of the trials that Thomas Karasic, MD is conducting.
What is the office address of Thomas Karasic, MD?
The office of Thomas Karasic, MD is located at: University of Pennsylvania, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.